These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39619829)

  • 1. Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study.
    Fischer S; Donhauser M; Cohnen S; Fietkau K; Vetter M; Grübel-Liehr M; Dietrich P; Rath T; Wilfer A; Sologub L; Krebs S; Dörje F; Nagore D; Meyer S; Neurath MF; Atreya R
    Therap Adv Gastroenterol; 2024; 17():17562848241301887. PubMed ID: 39619829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab for maintenance of medically-induced remission in Crohn's disease.
    Gordon M; Sinopoulou V; Akobeng AK; Sarian A; Moran GW
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD012609. PubMed ID: 38372447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "I've Spent My Whole Life Striving to Be Normal": Internalized Stigma and Perceived Impact of Diagnosis in Autistic Adults.
    Huang Y; Trollor JN; Foley KR; Arnold SRC
    Autism Adulthood; 2023 Dec; 5(4):423-436. PubMed ID: 38116050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cognitive behaviour therapy versus activity management, both delivered remotely, to treat paediatric chronic fatigue syndrome/myalgic encephalomyelitis: the UK FITNET-NHS RCT.
    Crawley E; Anderson E; Cochrane M; Shirkey BA; Parslow R; Hollingworth W; Mills N; Gaunt D; Treneman-Evans G; Rai M; Macleod J; Kessler D; Pitts K; Cooper S; Loades M; Annaw A; Stallard P; Knoop H; Van de Putte E; Nijhof S; Bleijenberg G; Metcalfe C
    Health Technol Assess; 2024 Oct; 28(70):1-134. PubMed ID: 39485730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT.
    Coulton S; Nizalova O; Pellatt-Higgins T; Stevens A; Hendrie N; Marchand C; Vass R; Deluca P; Drummond C; Ferguson J; Waller G; Newbury-Birch D
    Public Health Res (Southampt); 2023 Mar; 11(3):1-77. PubMed ID: 37254608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repetitive Negative Thinking As a Transdiagnostic Prospective Predictor of Depression and Anxiety Symptoms in Neurodiverse First-Semester College Students.
    McKenney EE; Brunwasser SM; Richards JK; Day TC; Kofner B; McDonald RG; Williams ZJ; Gillespie-Lynch K; Kang E; Lerner MD; Gotham KO
    Autism Adulthood; 2023 Dec; 5(4):374-388. PubMed ID: 38116057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen for adults with hepatocellular carcinoma.
    Naing C; Ni H; Aung HH
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD014869. PubMed ID: 39132750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosimilar monoclonal antibodies for cancer treatment in adults.
    Galvao TF; Livinalli A; Lopes LC; Zimmermann IR; Silva MT
    Cochrane Database Syst Rev; 2024 Nov; 11(11):CD013539. PubMed ID: 39607013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What Are the Functional, Radiographic, and Survivorship Outcomes of a Modified Cup-cage Technique for Pelvic Discontinuity?
    Mu W; Xu B; Wahafu T; Wang F; Guo W; Zou C; Cao L
    Clin Orthop Relat Res; 2024 Dec; 482(12):2149-2160. PubMed ID: 38991223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using Experience Sampling Methodology to Capture Disclosure Opportunities for Autistic Adults.
    Love AMA; Edwards C; Cai RY; Gibbs V
    Autism Adulthood; 2023 Dec; 5(4):389-400. PubMed ID: 38116059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD007807. PubMed ID: 32851663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial.
    Kim P; Sanchez AM; Penke TJR; Tuson HH; Kime JC; McKee RW; Slone WL; Conley NR; McMillan LJ; Prybol CJ; Garofolo PM
    Lancet Infect Dis; 2024 Dec; 24(12):1319-1332. PubMed ID: 39134085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohort.
    Suárez Ferrer C; Mesonero Gismero F; Caballol B; Ballester MP; Bastón Rey I; Castaño García A; Miranda Bautista J; Saiz Chumillas R; Benitez JM; Sanchez-Delgado L; López-García A; Rubin de Celix C; Alonso Abreu I; Melcarne L; Plaza Santos R; Marques-Camí M; Caballero Mateos A; Gómez Díez C; Calafat M; Galan HA; Vega Vilaamil P; Castro Senosiain B; Guerro Moya A; Rodriguez Diaz CY; Spicakova K; Manceñido Marcos N; Molina G; de Castro Parga L; Rodriguez Angulo A; Cuevas Del Campo L; Rodriguez Grau MDC; Ramirez F; Gomez Pastrana B; Gonzalez Partida I; Botella Mateu B; Peña Gonzalez E; Iyo E; Elosua Gonzalez A; Sainz Arnau E; Hernandez Villalba L; Perez Galindo P; Torrealba Medina L; Monsalve Alonso S; Olmos Perez JA; Dueñas Sadornil C; Garcia Ramirez L; Martín-Arranz MD; López Sanroman A; Fernández A; Merino Murgui V; Calviño Suárez C; Flórez-Diez P; Lobato Matilla ME; Sicilia B; Soto Escribano P; Maroto Martin C; Mañosa M; Barreiro-De Acosta M;
    Gastroenterol Hepatol; 2024 Dec; 47(10):502197. PubMed ID: 38710465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of prediction models for fetal growth restriction and birthweight: an individual participant data meta-analysis.
    Allotey J; Archer L; Coomar D; Snell KI; Smuk M; Oakey L; Haqnawaz S; Betrán AP; Chappell LC; Ganzevoort W; Gordijn S; Khalil A; Mol BW; Morris RK; Myers J; Papageorghiou AT; Thilaganathan B; Da Silva Costa F; Facchinetti F; Coomarasamy A; Ohkuchi A; Eskild A; Arenas Ramírez J; Galindo A; Herraiz I; Prefumo F; Saito S; Sletner L; Cecatti JG; Gabbay-Benziv R; Goffinet F; Baschat AA; Souza RT; Mone F; Farrar D; Heinonen S; Salvesen KÅ; Smits LJ; Bhattacharya S; Nagata C; Takeda S; van Gelder MM; Anggraini D; Yeo S; West J; Zamora J; Mistry H; Riley RD; Thangaratinam S
    Health Technol Assess; 2024 Aug; 28(47):1-119. PubMed ID: 39252507
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.